10 employees
Activiomics develops phosphoproteomics solutions for biomarker discovery and drug candidate profiling.
2009
$805K
from 1 investors over 1 rounds
ACTIVIOMICS LIMITED raised $805K on March 15, 2011
Investors: IP Group plc